These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Critical evaluation of platelet-inhibiting drugs in thrombotic disease. Harker LA; Hirsh J; Gent M; Genton E Prog Hematol; 1975; 9():229-54. PubMed ID: 766074 [No Abstract] [Full Text] [Related]
3. The current status of platelet suppressive drugs in the treatment of thrombosis. Hirsh J; Gent M; Genton E Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213 [No Abstract] [Full Text] [Related]
4. [Present situation of therapy with platelet aggregation inhibitors]. Poliwoda H Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157 [No Abstract] [Full Text] [Related]
6. Antiplatelet drugs in the management of patients with thrombotic disorders. Harker LA Semin Thromb Hemost; 1986 Apr; 12(2):134-55. PubMed ID: 3016905 [No Abstract] [Full Text] [Related]
7. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes. Sherry S Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782 [No Abstract] [Full Text] [Related]
8. [Platelet antiaggregants and arteriopathies]. Cristol R J Mal Vasc; 1981; 6(3):237-41. PubMed ID: 7026714 [No Abstract] [Full Text] [Related]
9. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease. Genton E Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166 [No Abstract] [Full Text] [Related]
10. [Clinical application and evaluation of anti-platelet agents]. Yasunaga K Nihon Rinsho; 1978 Dec; 36(12):3884-94. PubMed ID: 372628 [No Abstract] [Full Text] [Related]
11. [Prophylactic value of platelet anti-aggregants in coronary disease]. Verstraete M Clin Ter; 1979 Oct; 91(2):117-27. PubMed ID: 396098 [No Abstract] [Full Text] [Related]
12. Antiplatelet agents: a review. Gantmacher ML J R Soc Med; 1979 Jul; 72(7):513-9. PubMed ID: 399644 [No Abstract] [Full Text] [Related]
13. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts). Genton E; Gent M; Hirsh J; Harker LA N Engl J Med; 1975 Dec; 293(23):1174-8. PubMed ID: 1102977 [No Abstract] [Full Text] [Related]
14. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease? Poliwoda H; Avenarius HJ Int Angiol; 1986; 5(3):169-80. PubMed ID: 2435823 [TBL] [Abstract][Full Text] [Related]